IMNN
IMNN
NASDAQ · Biotechnology

Imunon Inc

$2.72
+0.01 (+0.37%)
Financial Highlights (FY 2025)
Revenue
4.58M
Net Income
640.0K
Gross Margin
60.5%
Profit Margin
14.0%
Rev Growth
+11.7%
D/E Ratio
0.17
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 60.5% 60.5% 60.5%
Operating Margin 15.9% 17.2% 18.6%
Profit Margin 14.0% 13.3% 14.3%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 4.58M 4.80M 3.77M
Gross Profit 2.77M 2.90M 2.28M
Operating Income 729.5K 823.3K 702.8K
Net Income 640.0K 637.0K 538.3K
Gross Margin 60.5% 60.5% 60.5%
Operating Margin 15.9% 17.2% 18.6%
Profit Margin 14.0% 13.3% 14.3%
Rev Growth +11.7% 0.0% +15.1%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 1.20M 1.25M 1.22M
Total Equity 6.87M 6.83M 6.69M
D/E Ratio 0.17 0.18 0.18
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 1.20M 1.08M 968.7K
Free Cash Flow 434.6K 468.2K 383.2K